Modulation of Factor 7 expression

Details for Australian Patent Application No. 2008323970 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Monia, Brett P.; Zhao, Chenguang; Freier, Susan M.; Crosby, Jeffrey R.; Zhang, Hong

Agent Davies Collison Cave

Pub. Number AU-A-2008323970

PCT Pub. Number WO2009/061851

Priority 60/986,928 09.11.07 US

Filing date 5 November 2008

Wipo publication date 14 May 2009

International Classifications

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61P 9/14 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

10 June 2010 PCT application entered the National Phase

  PCT publication WO2009/061851 Priority application(s): WO2009/061851

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323984-A method and apparatus for increasing the sensitivity of a biosensor used in a planar waveguide

2008323968-Extract of fraxinus excelsior seeds and therapeutic applications therefor